Low serum levels of high-density lipoprotein cholesterol and hypolipidaemic treatment.

Genovefa D Kolovou, Dennis V Cokkinos

Journal: Current medical research and opinion 2003;18(5):265-8

PMID: 12240788

Abstract

Low serum levels of high-density lipoprotein (HDL) cholesterol is an independent risk factor for coronary artery disease. Raising HDL cholesterol should be an important therapeutic goal in patients with coronary artery disease. Fibrates can reduce the risk of cardiac events and death from coronary artery disease.

Address: First Cardiology Department, Onassis Cardiac Surgery Center, Athens, Greece. [email protected]

DOI: 10.1185/030079902125000534

Link outs

Free resources

Medical:

https://medlineplus.gov/cholesterolmedicines.html

Subscription / membership required

Full Text Sources:

https://www.tandfonline.com/doi/10.1185/0300799021...

MeSH Terms: Cholesterol, LDL, Coronary Disease, Gemfibrozil, Humans, Hyperlipidemias, Hypolipidemic Agents, Risk Factors